Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Medical Microbiology and Immunology|October 6, 2021
Human cytomegalovirus multiple-strain infections and viral population diversity in haematopoietic stem cell transplant recipients analysed by high-throughput sequencingA Dhingra, J Götting, P R Varanasi, et al.Plos One|December 11, 2013
Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donorCarola E Bunse, Sylvia Borchers, Pavankumar R Varanasi, et al.Blood|July 14, 2010
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantationTobias Feuchtinger, Kathrin Opherk, Wolfgang A Bethge, et al.AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|July 11, 2012
LC Data QUEST: A Technical Architecture for Community Federated Clinical Data SharingKari A Stephens, Ching-Ping Lin, Laura-Mae Baldwin, et al.Annals of Hematology|July 25, 2023
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host diseaseMichael Stadler, Lothar Hambach, Elke Dammann, et al.Human Gene Therapy|November 25, 2010
Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantationSylvia Borchers, Elena Provasi, Anna Silvani, et al.Frontiers in Oncology|September 5, 2022
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysisMichael Stadler, Letizia Venturini, Ivonne Bünting, et al.Plos One|December 29, 2012
Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantationSylvia Borchers, Melanie Bremm, Thomas Lehrnbecher, et al.Hepatology (Baltimore, Md.)|March 5, 2011
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasisTim O Lankisch, Jochen Metzger, Ahmed A Negm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromesFelicitas Thol, Inna Friesen, Frederik Damm, et al.Pageof 15